In a large sample of 708 subjects ranging from cognitively normal to dementia, we thus determined whether higher CSF sTREM2 levels attenuate the association between ApoE4-carriage and future cognitive decline or MRI-assessed neurodegeneration. This evidence concerns the gene APOE and dementia.